Randomised double-blind study comparing tropisetron alone and in combination with dexamethasone in the prevention of acute and delayed cisplatin-induced emesis

By Garcia-del-Muro X.   Vadell C.   Perez Manga G.   Bover I.   Rifa J.   Beltran M.   Barros M.a.M.   Germa J.R.   Fabregat X.   Moreno V.   Salvador A.   Viladiu P.  

European Journal of Cancer, Vol. 34, Iss. 1, 1998-01 ,pp. : 193-195

Elsevier

Access to resources Recommend Favorite

Multicenter, randomized trial of ramosetron plus dexamethasone versus ramosetron alone in controlling cisplatin-induced emesis

By Villalon Antonio  

Supportive Care in Cancer, Vol. 12, Iss. 1, 2004-01 ,pp. : 58-63

Springer Publishing Company

Access to resources Recommend Favorite

Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration

By Maisano Roberto   Spadaro Pietro   Toscano Giuseppe   Caristi Nicola   Pergolizzi Stefano   Salimbeni Vincenzino  

Supportive Care in Cancer, Vol. 9, Iss. 1, 2001-01 ,pp. : 61-64

Springer Publishing Company

Access to resources Recommend Favorite

Control of Carboplatin-Induced Emesis with a Fixed Low Dose of Granisetron (0.5 mg) plus Dexamethasone

By Markman M.   Kennedy A.   Webster K.   Kulp B.   Peterson G.   Belinson J.  

Gynecologic Oncology, Vol. 60, Iss. 3, 1996-03 ,pp. : 435-437

Academic Press

Access to resources Recommend Favorite

Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis

By Cocquyt V.   Van Belle S.   Reinhardt R.R.   Decramer M.L.A.   O'Brien M.   Schellens J.H.M.   Borms M.   Verbeke L.   Van Aelst F.   De Smet M.   Carides A.D.   Eldridge K.   Gertz B.J.  

European Journal of Cancer, Vol. 37, Iss. 7, 2001-05 ,pp. : 835-842

Elsevier

Access to resources Recommend Favorite